I could be wrong on TLRY’ 20 percent German shareSome figures have it more to 25 percent now! With legalization in Germany it will only grow!
"That said, I believe the market’s reaction has overlooked the new law’s impact on the German cannabis market, since it will be easier for doctors to prescribe cannabis. Considering Tilray’s 25% market share in the German medical and therapeutic cannabis market, the expected growth of this market should increase its distribution segment’s revenues exponentially, which already accounts for 41% of the company’s total revenues as of the end of FY 2023.
Moreover, Tilray’s alcoholic beverages segment is seeing substantial growth as it continues to add brands under its umbrella. As a result, the alcohol segment’s share of Tilray’s total revenues has been increasing over the years. Considering that the craft beer market is expected to grow at a CAGR of 10.6% by 2032, I expect this segment to be a main contributor to Tilray’s profitability in the future thanks to its high margins. Based on these factors, I’m rating Tilray as a buy with a price target of $4.67 per share by the end of 2025, implying a 175% upside from current levels."